Related Experiment Videos
Tumor heterogeneity and progression: conceptual foundations for modeling
L D Greller1, F L Tobin, G Poste
1SmithKline Beecham Pharmaceuticals Research and Development, King of Prussia, PA 19406-0939, USA.
Invasion & Metastasis
|January 1, 1996
Summary
This study presents a conceptual framework for modeling tumor growth, progression, and heterogeneity. These models offer a consistent language to understand cancer dynamics and guide future research.
Area of Science:
- Oncology
- Computational Biology
- Mathematical Modeling
Background:
- Tumor progression, growth, and heterogeneity are complex phenomena.
- Understanding these dynamics is crucial for effective cancer treatment.
- Existing models may not fully capture the interplay of key driving factors.
Purpose of the Study:
- To present a conceptual foundation for modeling tumor progression, growth, and heterogeneity.
- To provide a framework for building both conceptual and mathematical cancer models.
- To aid in understanding, testing hypotheses, and guiding experiments in cancer research.
Main Methods:
- Developing a schema integrating three phenomenological driving elements: growth, progression, and genetic instability.
- Defining growth as changes in tumor bulk, distinct from progression.
- Defining progression as processes underlying phenotypic changes.
- Defining genetic elements as heritable changes affecting tumor behavior.
Main Results:
- The proposed framework allows for consistent qualitative reasoning about tumor behavior.
- Models can be built by combining the interactions of growth, progression, and genetic instability.
- These models can explore hypotheses regarding dynamic changes in cellular populations.
- Intratumor heterogeneity generation can be investigated using these models.
Conclusions:
- The conceptual foundation provides a versatile tool for studying dynamic aspects of complex tumor behavior.
- Models derived from this framework can guide experimentation and deepen insights into cancer progression.
- This approach facilitates 'in machina' modeling of cancer to address dynamic features.